Literature DB >> 23968711

Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.

Zhi-Hong Huang1, Shi-Tian Zhuo, Chun-Yan Li, Hua-Ting Xie, Ding Li, Jia-Heng Tan, Tian-Miao Ou, Zhi-Shu Huang, Lian-Quan Gu, Shi-Liang Huang.   

Abstract

Two series of novel C-9 chloro- and bromo-substituted mansonone E derivatives with triazole moieties at the C-3 position were prepared by using copper-catalysed azide-alkyne cycloaddition click chemistry. These compounds were found as potent inhibitors of topoisomerase II (Topo II) and topoisomerase I (Topo I). The Topo II-mediated pBR322 DNA relaxation and cleavage assay showed that the derivatives might act as catalytic inhibitors. Their cytotoxic activities against A549, HL-60, K562 and HeLa cells were evaluated, indicating that these compounds were potent antitumour agents. Their structure activity relationships and molecular docking study revealed that the substituents of the triazole were particularly important for cytotoxicity.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antitumour; Click chemistry; Cytotoxic activity; HPLC; HRMS; High Performance Liquid Chromatography; High Resolution Mass Spectrometer; ME; MF; MTT; Mansonone E; NMR; Topo; Topoisomerase; mansonone E; mansonone F; methyl thiazolyl tetrazolium; nuclear magnetic resonance; topoisomerase

Mesh:

Substances:

Year:  2013        PMID: 23968711     DOI: 10.1016/j.ejmech.2013.07.011

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors.

Authors:  Karolina Piecyk; Maciej Lukaszewicz; Edward Darzynkiewicz; Marzena Jankowska-Anyszka
Journal:  RNA       Date:  2014-08-22       Impact factor: 4.942

Review 2.  The application of click chemistry in the synthesis of agents with anticancer activity.

Authors:  Nan Ma; Ying Wang; Bing-Xin Zhao; Wen-Cai Ye; Sheng Jiang
Journal:  Drug Des Devel Ther       Date:  2015-03-12       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.